Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

As biotech turns 20...

Henry I Miller1

  • 1Hoover Institution, Stanford University, Stanford, California 94305-6010, USA. miller@hoover.stanford.edu

Nature Reviews. Drug Discovery
|December 4, 2002
PubMed
Summary
This summary is machine-generated.

Biotechnology has advanced pharmaceuticals, but challenges remain. Over-regulation and high costs hinder biopharmaceutical companies from bringing new, essential medicines to patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Will the Biden administration 'follow the science' on regulatory reform?

Nature biotechnology·2021
Same author

COVID-19 Testing Tests Our Mettle.

Missouri medicine·2020
Same author

The Feds Act to Boost Competition in the Biosimilars Market.

Missouri medicine·2020
Same author

China's Coronavirus-Induced Paralysis Threatens U.S. Drug Supply Chain.

Missouri medicine·2020
Same author

Flawed scientific studies block progress and sow confusion.

GM crops & food·2020
Same author

We Can use Market Forces to Moderate Drug Prices.

Missouri medicine·2020
Same journal

R&D productivity trends for biopharma companies in Asia and emerging markets.

Nature reviews. Drug discovery·2026
Same journal

Growth in clinical research capability in China and impact on the pharmaceutical sector.

Nature reviews. Drug discovery·2026
Same journal

Circular RNA guides exon skipping in DMD.

Nature reviews. Drug discovery·2026
Same journal

p38α inhibition restores axonal transport.

Nature reviews. Drug discovery·2026
Same journal

Inflammatory bowel disease-on-a-chip.

Nature reviews. Drug discovery·2026
Same journal

Designing GPCR-targeted miniproteins.

Nature reviews. Drug discovery·2026
See all related articles

Area of Science:

  • Biopharmaceutical innovation
  • Pharmaceutical development
  • Biotechnology applications in medicine

Background:

  • Biotechnology has significantly impacted pharmaceutical development over the last two decades.
  • Despite advancements, the biopharmaceutical industry faces considerable hurdles.
  • Numerous companies are competing for limited product development opportunities.

Approach:

  • Analysis of the biopharmaceutical landscape.
  • Evaluation of regulatory and economic factors in drug development.
  • Assessment of the impact of biotechnology on pharmaceutical products.

Key Points:

  • The biopharmaceutical sector has seen major contributions from biotechnology.
  • Key challenges include over-regulation and the high cost of testing and market entry.

Related Experiment Videos

  • A high number of companies are pursuing a limited number of drug candidates.

    • Conclusions:

    • Biotechnology continues to offer potential benefits for patients and healthcare costs.
    • The current industry structure, characterized by intense competition and high development expenses, poses significant risks.
    • Addressing regulatory and cost barriers is crucial for sustained innovation in biopharmaceuticals.